Understanding seroprevalence of dengue virus and its health surveillance impacts
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 506725
Grant search
Key facts
Disease
Denguestart year
2024Known Financial Commitments (USD)
$4,393.39Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Selemon AnabelResearch Location
CanadaLead Research Institution
University of CalgaryResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Immunity
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Seroprevalence studies are imperative to estimate the true level of dengue virus infection in susceptible areas and provide necessary insights informing vaccination strategies. However, this research is scattered and decentralized, therefore difficult to apply to public health solutions. This research project aims to: a) centralize and synthesize global dengue seroprevalence studies through a systematic review and b) pilot some early exploratory analyses in region-focused dengue seroprevalence. The ultimate goal is to contribute valuable foundational insights on meta-analyzing arbovirus and dengue seroprevalence and will form the basis of further impactful work in integrated global dengue surveillance approaches. The student will work within the Centre for Health Informatics' SeroTracker team at the University of Calgary. SeroTracker is an internationally recognized initiative that monitors, combines, synthesizes, and presents all COVID-19 seroprevalence information available globally. This student will expand SeroTracker to a new global health concern surrounding arbovirus (specifically tracking seroprevalence of Dengue Fever).